The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment (Q34550618)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

Siegfried Kasper

2

object named as

Siegfried Kasper

0 references

object named as

Heinz Grunze

1

0 references

Hans-Jürgen Möller

5

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

object named as

Guy Goodwin

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Charles Bowden

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

WFSBP Task Force on Treatment Guidelines for Bipolar Disorders

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

120-135

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Switch from depression to mania--a record study over decades between 1920 and 1982.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A new bipolar spectrum concept: a brief review

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Maintenance therapies for classic and other forms of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Clinical studies on the use of lamotrigine in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

The enduring psychosocial consequences of mania and depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Clinical Factors in Lithium Carbonate Prophylaxis Failure

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Suicide risk in bipolar disorder during treatment with lithium and divalproex

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders?

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Outcome in the pharmacologic treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Recurrence in affective disorder. I. Case register study.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Rapid recurrence of mania following abrupt discontinuation of lithium

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Expanding the group of bipolar disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Possible interaction between fluoxetine and pimozide causing sinus bradycardia

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium-discontinuation-induced refractoriness: preliminary observations.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A review of continuation and maintenance electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Bipolar II disorder and suicidal behavior

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Response to maintenance therapy in bipolar illness. Effect of index episode.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Discontinuation of maintenance treatment in bipolar disorder: risks and implications

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lamotrigine for the treatment of bipolar disorder: a clinical case series.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Olanzapine versus divalproex in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapy.

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Lithium use and discontinuation in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Suicidal Behavior in Bipolar I and Bipolar II Disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Differential features between bipolar I and bipolar II disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029924

21 January 2018

Identifiers

10.1080/15622970410029924

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34550618&oldid=1714004394"